News

The transaction provides Amgen with a late-stage phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on hemodialysis. The deal was originally announced June 4.

In a press release, MedImmune said that the trial is the third clinical study of the antibody currently underway. MEDI-545 is also being evaluated in a single-dose Phase

TAK-491 is an angiotensin receptor blocker (ARB) discovered by Takeda that lowers blood pressure. Takeda said that TAK-491 is expected to show stronger anti-hypertensive action, and also to

Additional preliminary results from preclinical tests in small animals on Viprovex in conjunction with Tamiflu (Roche’s FDA-approved influenza prophylactic and treatment) show that treating subjects with both Viprovex

The product candidate underlying the agreement is being developed to treat a significant CNS disorder and is based on Antares’ proprietary ATD (Advanced Transdermal Delivery) drug delivery platform,

Up to 24 Alzheimer’s patients at the “mild to moderate” disease stage are to be vaccinated, with the aim of this initial phase I trial being to demonstrate

This will allow Cougar to conduct a Phase I clinical trial of CB3304, an orally active inhibitor of microtubule dynamics, for the treatment of relapsed or refractory multiple

First quarter 2009 product revenues consisted of $1.3 million in Celution System sales in Europe and Asia and the recognition of $0.6 million from the installation of a

The positive opinion was reached after the the European Committee for Human Medicinal Products reviewed data from clinical trials in almost 30,000 females, including data from the largest